This was sent to me by a friend who is an MD. She rightly identified this dangerous situation as a "drug driving a superficial illness deep inside the body":
Efalizumab Withdrawn From US Market
Efalizumab (Raptiva), used for the treatment of psoriasis, will no longer be available in the United States because of the risk for progressive multifocal leukoencephalopathy.
Added by Jolinda Rockett on April 10, 2009 at 11:05am —